Navigation Links
MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015
Date:11/12/2010

MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by... -- DALLAS, November 12, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services, Economic News, Trends, Analysis Click to view news release full screen  

MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015

 

DALLAS, November 12, 2010 /PRNewswire/ -- The 'Top 10 drug discovery technologies (http://www.marketsandmarkets.com/Market-Reports/drug-discovery-41.html) - strategic analysis and global forecasts (2010 to 2015)' analyzes the top 10 drug discovery technologies with respect to market drivers, opportunities and trends in the diverse geographical regions including North America, Europe, Asia and rest of the world.

Browse market data tables and in-depth TOC on Top 10 drug discovery technologies - strategic analysis and global forecasts (2010 to 2015)

http://www.marketsandmarkets.com/Market-Reports/drug-discovery-41.html

Early buyers will receive 10% customization of reports.

The slow growth of the introduction of new blockbuster drugs is a major concern which the drug development companies are catering to by using these top technologies. The increasing utilization of HTS in the lead generation and increasing adoption of the technology by the academia are some of the prime market boosters for high throughput screening.

The global top 10 drug discovery technologies market is expected to be around $30.8 billion in 2010 and estimated to reach $54 billion mark in 2015, growing at a CAGR of 11.9% from 2010-2015. The market for high throughput screening accounts for the largest share with approximately 33% of the entire market for top 10 drug discovery technologies. This huge market share is mainly due to the increasing applications of cell based assays and robotics in the parallel screening of compounds.

Scope of the report This research report includes following drug discovery technologies: - High throughput screening (robotics and automation, cell based assays, miniaturization, high content screening and ultra high throughput screening) - Bioanalytical instruments (mass spectrometry, NMR, micro plate readers and chemotherapy instruments) - Pharmacogenomics - Combinatorial chemistry - Genomics (functional and structural genomics) - Biochips (DNA microarrays, lab on a chip, proteomics microarrays) - Bioinformatics - Proteomics (2DGE, two hybrid systems, isotope encoding and activity based assays) - RNAi (siRNA, miRNA, ddRNAi, short hairpin RNAs) - Nanotechnology (Atomic force microscopy, nano mass spectroscopy, dip pen nanolithography and other nanotechnologies)

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

Contact: Ms. Sunita 7557 Rambler Road Suite 727, Dallas, TX 75231 Tel: +1-888-989-8004 Email: sales@marketsandmarkets.com http://www.marketsandmarkets.com http://marketsandmarkets.wordpress.com/ http://marketsandmarkets.blogspot.com/
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
2. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
3. MarketsandMarkets: Patient Monitoring Devices Markets in Brazil, Russia, India and China Worth $2,992 Million by 2015
4. MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015
5. MarketsandMarkets: Global Minimally Invasive Surgery (MIS) Market Worth US$ 90.4 Billion by 2015.
6. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
7. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
8. Directors Forum: PEPFAR and the Global AIDS Response
9. Alfacell Corporation to Present at UBS Global Life Sciences Conference
10. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
11. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):